75 related articles for article (PubMed ID: 19425200)
1. Polymorphism of cytochrome P450 2B6 and prostate cancer risk: a significant association in a Japanese population.
Kurosaki T; Suzuki M; Enomoto Y; Arai T; Sawabe M; Hosoi T; Homma Y; Kitamura T
Int J Urol; 2009 Apr; 16(4):364-8. PubMed ID: 19425200
[TBL] [Abstract][Full Text] [Related]
2. TMPRSS2 Met160Val polymorphism: significant association with sporadic prostate cancer, but not with latent prostate cancer in Japanese men.
Maekawa S; Suzuki M; Arai T; Suzuki M; Kato M; Morikawa T; Kasuya Y; Kume H; Kitamura T; Homma Y
Int J Urol; 2014 Dec; 21(12):1234-8. PubMed ID: 25040002
[TBL] [Abstract][Full Text] [Related]
3. CYP3A5 gene polymorphism and risk of prostate cancer in a Japanese population.
Zhenhua L; Tsuchiya N; Narita S; Inoue T; Horikawa Y; Kakinuma H; Kato T; Ogawa O; Habuchi T
Cancer Lett; 2005 Jul; 225(2):237-43. PubMed ID: 15876487
[TBL] [Abstract][Full Text] [Related]
4. Identification of CYP2B6 sequence variants by use of multiplex PCR with allele-specific genotyping.
Jacob RM; Johnstone EC; Neville MJ; Walton RT
Clin Chem; 2004 Aug; 50(8):1372-7. PubMed ID: 15178651
[TBL] [Abstract][Full Text] [Related]
5. Association of rs6983561 polymorphism at 8q24 with prostate cancer mortality in a Japanese population.
Suzuki M; Liu M; Kurosaki T; Suzuki M; Arai T; Sawabe M; Kasuya Y; Kato M; Fujimura T; Fukuhara H; Enomoto Y; Nishimatsu H; Ishikawa A; Kume H; Homma Y; Kitamura T
Clin Genitourin Cancer; 2011 Sep; 9(1):46-52. PubMed ID: 21700508
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms of fibroblast growth factor receptor 4 have association with the development of prostate cancer and benign prostatic hyperplasia and the progression of prostate cancer in a Japanese population.
Ma Z; Tsuchiya N; Yuasa T; Inoue T; Kumazawa T; Narita S; Horikawa Y; Tsuruta H; Obara T; Saito M; Satoh S; Ogawa O; Habuchi T
Int J Cancer; 2008 Dec; 123(11):2574-9. PubMed ID: 18756523
[TBL] [Abstract][Full Text] [Related]
7. Association of SNP rs1447295 and microsatellite marker DG8S737 with familial prostate cancer and high grade disease.
Hamano T; Matsui H; Sekine Y; Ohtake N; Nakata S; Suzuki K
J Urol; 2010 Aug; 184(2):738-42. PubMed ID: 20639049
[TBL] [Abstract][Full Text] [Related]
8. Effects of the selected cytochrome P450 oxidoreductase genetic polymorphisms on cytochrome P450 2B6 activity as measured by bupropion hydroxylation.
Lv J; Hu L; Zhuo W; Zhang C; Zhou H; Fan L
Pharmacogenet Genomics; 2016 Feb; 26(2):80-7. PubMed ID: 26580670
[TBL] [Abstract][Full Text] [Related]
9. Significance of vitamin D receptor gene polymorphism for risk and disease severity of prostate cancer and benign prostatic hyperplasia in Japanese.
Hamasaki T; Inatomi H; Katoh T; Ikuyama T; Matsumoto T
Urol Int; 2002; 68(4):226-31. PubMed ID: 12053022
[TBL] [Abstract][Full Text] [Related]
10. Association study of cytochrome P450 1A1*2A polymorphism with prostate cancer risk and aggressiveness in Croatians.
Mandić S; Horvat V; Marczi S; Lukić I; Galić J
Coll Antropol; 2014 Mar; 38(1):141-6. PubMed ID: 24851608
[TBL] [Abstract][Full Text] [Related]
11. Association of lipoprotein lipase gene polymorphism with risk of prostate cancer in a Japanese population.
Narita S; Tsuchiya N; Wang L; Matsuura S; Ohyama C; Satoh S; Sato K; Ogawa O; Habuchi T; Kato T
Int J Cancer; 2004 Dec; 112(5):872-6. PubMed ID: 15386377
[TBL] [Abstract][Full Text] [Related]
12. Cytochrome 2B6 polymorphism and efavirenz-induced central nervous system symptoms : a substudy of the ANRS ALIZE trial.
Gallien S; Journot V; Loriot MA; Sauvageon H; Morlat P; Reynes J; Reliquet V; Chêne G; Molina JM;
HIV Med; 2017 Sep; 18(8):537-545. PubMed ID: 28145050
[TBL] [Abstract][Full Text] [Related]
13. Association of the genetic polymorphism in cytochrome P450 (CYP) 1A1 with risk of familial prostate cancer in a Japanese population: a case-control study.
Suzuki K; Matsui H; Nakazato H; Koike H; Okugi H; Hasumi M; Ohtake N; Nakata S; Takei T; Hatori M; Ito K; Yamanaka H
Cancer Lett; 2003 Jun; 195(2):177-83. PubMed ID: 12767526
[TBL] [Abstract][Full Text] [Related]
14. Cytochrome P450 2B6 is a growth-inhibitory and prognostic factor for prostate cancer.
Kumagai J; Fujimura T; Takahashi S; Urano T; Ogushi T; Horie-Inoue K; Ouchi Y; Kitamura T; Muramatsu M; Blumberg B; Inoue S
Prostate; 2007 Jul; 67(10):1029-37. PubMed ID: 17455229
[TBL] [Abstract][Full Text] [Related]
15. Association between NAT2, CYP1A1, and CYP1A2 genotypes, heterocyclic aromatic amines, and prostate cancer risk: a case control study in Japan.
Koda M; Iwasaki M; Yamano Y; Lu X; Katoh T
Environ Health Prev Med; 2017 Oct; 22(1):72. PubMed ID: 29165164
[TBL] [Abstract][Full Text] [Related]
16. Allele and Genotype Frequencies of Cytochrome P450 2B6 516G>T Single Nucleotide Polymorphism in HIV-Negative and HIV-Infected Adult Nigerian Populations.
Saʼad Toyin A; Julius Olugbenga S; Rahman Ayodele B; Olusola Joseph O; Taibat Moji BO
Am J Ther; 2016; 23(6):e1715-e1719. PubMed ID: 26938766
[TBL] [Abstract][Full Text] [Related]
17. N-acetyltransferase-2 gene polymorphism as a possible biomarker for prostate cancer in Japanese men.
Hamasaki T; Inatomi H; Katoh T; Aono H; Ikuyama T; Muratani T; Matsumoto T
Int J Urol; 2003 Mar; 10(3):167-73. PubMed ID: 12622714
[TBL] [Abstract][Full Text] [Related]
18. Significance of an E-cadherin gene promoter polymorphism for risk and disease severity of prostate cancer in a Japanese population.
Goto T; Nakano M; Ito S; Ehara H; Yamamoto N; Deguchi T
Urology; 2007 Jul; 70(1):127-30. PubMed ID: 17656222
[TBL] [Abstract][Full Text] [Related]
19. Genetic polymorphism in sex hormone metabolism and prostate cancer risk.
Ersekerci E; Sofikerim M; Taheri S; Demirtas A; Halis F
Genet Mol Res; 2015 Jul; 14(3):7326-34. PubMed ID: 26214411
[TBL] [Abstract][Full Text] [Related]
20. HPC2/ELAC2 polymorphism associated with Japanese sporadic prostate cancer.
Yokomizo A; Koga H; Kinukawa N; Tsukamoto T; Hirao Y; Akaza H; Mori M; Naito S
Prostate; 2004 Nov; 61(3):248-52. PubMed ID: 15368467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
